Chemical Biology Applications in Drug Discovery

Session Chair - Not Funded(s)

• 

  Douglas Auld, PhD

  Associate Director
  Novartis, Massachusetts, United States

Presentations:

• 4:00 PM – 4:30 PM

  Phenotypic quantitative high-throughput screening with Caenorhabditis elegans as a chemical physiology platform for drug discovery
  

  James Inglese, PhD – National Center for Advancing Translational Sciences (NCATS), NIH
• 4:30 PM – 5:00 PM

  Binding site hotspot mapping with photo-affinity labeling
  

  Christina Woo, PhD – Harvard University
• 5:00 PM – 5:30 PM

  Chemoproteomics applications for target deconvolution, mapping of druggable pockets and exploration of novel modalities
  

  Markus Schirle, PhD – Novartis